Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of β-catenin protein level
Tài liệu tham khảo
Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Ca - Cancer J. Clin., 71, 209, 10.3322/caac.21660
Shaukat, 2022, Current and future colorectal cancer screening strategies, Nat. Rev. Gastroenterol. Hepatol.
Arnold, 2017, Global patterns and trends in colorectal cancer incidence and mortality, Gut, 66, 683, 10.1136/gutjnl-2015-310912
Weiser, 2018, AJCC 8th edition: colorectal cancer, Ann. Surg Oncol., 25, 1454, 10.1245/s10434-018-6462-1
Keum, 2019, Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies, Nat. Rev. Gastroenterol. Hepatol., 16, 713, 10.1038/s41575-019-0189-8
Ferrè, 2015, Revealing protein–lncRNA interaction, Briefings Bioinf., 17, 106, 10.1093/bib/bbv031
Winkle, 2021, Noncoding RNA therapeutics—challenges and potential solutions, Nat. Rev. Drug Discov., 20, 629, 10.1038/s41573-021-00219-z
Li, 2022
Kortam, 2023, MAGI2-AS3 and miR-374b-5p as putative regulators of multiple sclerosis via modulating the PTEN/AKT/IRF-3/IFN-β Axis: new clinical insights, ACS Chem. Neurosci., 14, 1107, 10.1021/acschemneuro.2c00653
Statello, 2021, Gene regulation by long non-coding RNAs and its biological functions, Nat. Rev. Mol. Cell Biol., 22, 96, 10.1038/s41580-020-00315-9
Bolha, 2017, Long noncoding RNAs as biomarkers in cancer, Dis. Markers, 2017, 10.1155/2017/7243968
Jiang, 2019, Emerging roles of lncRNA in cancer and therapeutic opportunities, Am. J. Cancer Res., 9, 1354
Rasool, 2016, Non-coding RNAs in cancer diagnosis and therapy, Non-coding RNA Res., 1, 69, 10.1016/j.ncrna.2016.11.001
Huarte, 2015, The emerging role of lncRNAs in cancer, Nat. Med., 21, 1253, 10.1038/nm.3981
Chen, 2019, Computational models for lncRNA function prediction and functional similarity calculation, Brief. Funct. Genom., 18, 58, 10.1093/bfgp/ely031
Feng, 1995, The RNA component of human telomerase, Science, 269, 1236, 10.1126/science.7544491
Gala, 2021, Long non-coding RNAs at work on telomeres: functions and implications in cancer therapy, Cancer Lett., 502, 120, 10.1016/j.canlet.2020.12.036
Li, 2005, Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA, J. Biol. Chem., 280, 23709, 10.1074/jbc.M502782200
He, 2012, Genomic amplification of hTERC in paraffin-embedded tissues of cervical intraepithelial neoplasia and invasive cancer, Int. J. Gynecol. Pathol., 31, 280, 10.1097/PGP.0b013e318237d50a
Flacco, 2015, MYC and human telomerase gene (TERC) copy number gain in early-stage non–small cell lung cancer, Am. J. Clin. Oncol., 38, 152, 10.1097/COC.0000000000000012
Baena‐Del Valle, 2018, MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer, J. Pathol., 244, 11, 10.1002/path.4980
Novakovic, 2004, Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer, Oncol. Rep., 11, 245
Kim, 2016, Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer, Mol. Cell. Endocrinol., 431, 36, 10.1016/j.mce.2016.05.002
Hu, 2023, Long non‐coding RNA telomerase RNA elements improve glucocorticoid‐induced osteoporosis by EZH2 to regulate DKK1, Int. J. Rheumat. Dis., 1
Yokoyama, 2019, In vitro and in vivo studies on the association of long non-coding RNAs H19 and urothelial cancer associated 1 with the susceptibility to 5-fluorouracil in rectal cancer, Int. J. Oncol., 55, 1361
Zuo, 2021, Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer, Aging (Albany NY), 13, 4182, 10.18632/aging.202383
Edge, 2010, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM, Ann. Surg Oncol., 17, 1471, 10.1245/s10434-010-0985-4
Sharma, 2022, Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis, Comput. Biol. Med., 146, 10.1016/j.compbiomed.2022.105688
Nguyen, 2020, Pathways of colorectal carcinogenesis, Gastroenterology, 158, 291, 10.1053/j.gastro.2019.08.059
Mehana, 2022, LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Behçet's disease and systemic lupus erythematosus, Life Sci., 309, 10.1016/j.lfs.2022.120965
Bhan, 2017, Long noncoding RNA and cancer: a new paradigm, Cancer Res., 77, 3965, 10.1158/0008-5472.CAN-16-2634
Bridges, 2021, LNCcation: lncRNA localization and function, JCB (J. Cell Biol.), 220
Rizk, 2022
Fernandes, 2019, Long non-coding RNAs in the regulation of gene expression: physiology and disease, Non-coding RNA, 5, 17, 10.3390/ncrna5010017
Chen, 2017, Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis, Cancer Med., 6, 2321, 10.1002/cam4.1168
Kalmár, 2019, Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition, BMC Cancer, 19, 1059, 10.1186/s12885-019-6180-5
He, 2021, Structures of telomerase at several steps of telomere repeat synthesis, Nature, 593, 454, 10.1038/s41586-021-03529-9
Huang, 2022
Chen, 2022, Urinary exosomal long noncoding RNA TERC as a noninvasive diagnostic and prognostic biomarker for bladder urothelial carcinoma, J. Immunol. Res., 2022
Xu, 2020, Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer, Int. J. Cancer, 146, 2901, 10.1002/ijc.32747
Kushner, 2000, 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells, Gynecol. Oncol., 76, 183, 10.1006/gyno.1999.5668
Rossi, 2020, Noncoding RNAs controlling telomere homeostasis in senescence and aging, Trends Mol. Med., 26, 422, 10.1016/j.molmed.2020.01.010
Wang, 2005, Overexpressed β-catenin blocks nitric oxide–induced apoptosis in colonic cancer cells, Cancer Res., 65, 8604, 10.1158/0008-5472.CAN-05-1169
Xia, 2018, Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway, Biochem. Biophys. Res. Commun., 503, 385, 10.1016/j.bbrc.2018.06.045
Liu, 2011, β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells, Med. Oncol., 28, 608, 10.1007/s12032-010-9476-5
Pignolo, 2008, Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis, Aging Cell, 7, 23, 10.1111/j.1474-9726.2007.00350.x
Bruedigam, 2014, Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy, Cell Stem Cell, 15, 775, 10.1016/j.stem.2014.11.010
Blasco, 1997, Telomere shortening and tumor formation by mouse cells lacking telomerase RNA, Cell, 91, 25, 10.1016/S0092-8674(01)80006-4
Herrera, 2000, Impaired germinal center reaction in mice with short telomeres, EMBO J., 19, 472, 10.1093/emboj/19.3.472
Flores, 2008, The longest telomeres: a general signature of adult stem cell compartments, Gene Dev., 22, 654, 10.1101/gad.451008
Deng, 2008, Telomere dysfunction and tumour suppression: the senescence connection, Nat. Rev. Cancer, 8, 450, 10.1038/nrc2393
Kinzler, 1996, Lessons from hereditary colorectal cancer, Cell, 87, 159, 10.1016/S0092-8674(00)81333-1
Nakayama, 2019, Mutant p53 in colon cancer, J. Mol. Cell Biol., 11, 267, 10.1093/jmcb/mjy075
Cho, 2020, 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation, Nat. Commun., 11, 1, 10.1038/s41467-020-19173-2
Morita, 2018, Heart failure as an aging-related phenotype wnt/β-catenin signaling and p53 pathway, Int. Heart J., 59, 6, 10.1536/ihj.17-519
Mukai, 2000, 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas, Cancer Res., 60, 4461
Kondo, 1998, Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA, Oncogene, 16, 3323, 10.1038/sj.onc.1201885